CAI
Caris Life Sciences Inc.

839
Mkt Cap
$5.92B
Volume
3.64M
52W High
$42.50
52W Low
$20.27
PE Ratio
-8.59
CAI Fundamentals
Price
$19.53
Prev Close
$20.85
Open
$20.64
50D MA
$25.57
Beta
0.01
Avg. Volume
2.65M
EPS (Annual)
-$1.35
P/B
12.30
Loading...
Loading...
News
all
press releases
Caris Life Sciences (NASDAQ:CAI) Downgraded to Hold Rating by Wall Street Zen
Wall Street Zen cut Caris Life Sciences from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Shares Down 7.7% - Here's Why
Caris Life Sciences (NASDAQ:CAI) Stock Price Down 7.7% - Here's What Happened...
MarketBeat·1d ago
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Upgraded at Robert W. Baird
Robert W. Baird upgraded shares of Caris Life Sciences to a "strong-buy" rating in a research report on Tuesday...
MarketBeat·4d ago
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Sets New 12-Month Low - Here's What Happened
Caris Life Sciences (NASDAQ:CAI) Sets New 52-Week Low - Here's What Happened...
MarketBeat·5d ago
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Reaches New 1-Year Low - Should You Sell?
Caris Life Sciences (NASDAQ:CAI) Sets New 1-Year Low - Time to Sell...
MarketBeat·10d ago
News Placeholder
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26 Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26 PR...
PR Newswire·13d ago
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Upgraded by Wall Street Zen to "Buy" Rating
Wall Street Zen upgraded shares of Caris Life Sciences from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Trading Down 9.8% - Here's What Happened
Caris Life Sciences (NASDAQ:CAI) Trading Down 9.8% - What's Next...
MarketBeat·1mo ago
News Placeholder
Caris Life Sciences Shares Rise More Than 3% In Pre-market As Q4 Prel Revenue Surges 116%
(RTTNews) - Caris Life Sciences Inc. (CAI), an artificial intelligence TechBio company, Monday reported that its preliminary fourth quarter revenue and full year revenue have increased by 116 percent...
Nasdaq News: Markets·1mo ago
News Placeholder
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results PR Newswire IRVING, Texas, Jan...
PR Newswire·1mo ago
<
1
2
...
>

Latest CAI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.